Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07500363 · ClinicalTrials.gov registry record · NA
Improving Caregiver Engagement in Early Interventions
A NA study, sponsored by University of California, Davis.
- Not yet
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT07500363: Clinical Trial NA study, sponsored by University of California, Davis.
NCT07500363 is a NA study that has not yet begun recruiting, run by University of California, Davis. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07500363, a NA study, has not yet begun recruiting, sponsored by University of California, Davis.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The goal of this study is to test the effectiveness of the FANS-EI program in supporting caregiver engagement in caregiver-mediated early interventions for young children with autism. This study also examines caregiver-perceived social support and self-efficacy and FANS-EI implementation outcomes (feasibility, acceptability, appropriateness).
Primary Outcome
The 5-item Parent Participatory Engagement Measure (PPEM) examines caregiver comfort with, engagement and participation in the intervention.
Interventions
- BEHAVIORAL Early Intervention
- BEHAVIORAL FANS-EI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2026-07 |
| Est. Completion | 2028-12 |
| Phase | NA |
What is known before NCT07500363 opens enrollment
NCT07500363 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Early Intervention is the first listed.
NCT07500363 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07500363 about?
NCT07500363 is a clinical study titled "Improving Caregiver Engagement in Early Interventions". The goal of this study is to test the effectiveness of the FANS-EI program in supporting caregiver engagement in caregiver-mediated early interventions for young children with autism. This study also examines caregiver-perceived social support and self-efficacy and FANS-EI implementation outcomes (f...
What is the current status of trial NCT07500363?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2026-07. Estimated completion is 2028-12.
What interventions are being tested in trial NCT07500363?
The interventions under investigation include: Early Intervention (BEHAVIORAL), FANS-EI (BEHAVIORAL).
Who is sponsoring clinical trial NCT07500363?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07500363's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia